Shigeyoshi Fujimoto

2.1k total citations
49 papers, 1.7k citations indexed

About

Shigeyoshi Fujimoto is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Shigeyoshi Fujimoto has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 22 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Shigeyoshi Fujimoto's work include Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (19 papers) and Immune Cell Function and Interaction (18 papers). Shigeyoshi Fujimoto is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (19 papers) and Immune Cell Function and Interaction (18 papers). Shigeyoshi Fujimoto collaborates with scholars based in Japan, Canada and United States. Shigeyoshi Fujimoto's co-authors include A.H. Sehon, Mark I. Greene, Mark I. Greene, Tomio Tada, Hiroshi Yamamoto, Yasuhiro Nagai, Xiaomin Song, Guoping Deng, Ciriaco A. Piccirillo and Kunio Nakagawa and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Shigeyoshi Fujimoto

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeyoshi Fujimoto Japan 20 1.1k 559 448 207 116 49 1.7k
S. C. Bansal United States 14 831 0.7× 365 0.7× 302 0.7× 266 1.3× 118 1.0× 23 1.4k
A Mazumder United States 10 1.9k 1.7× 887 1.6× 337 0.8× 302 1.5× 141 1.2× 17 2.4k
F W Ruscetti United States 17 982 0.9× 475 0.8× 685 1.5× 102 0.5× 134 1.2× 33 2.0k
KA Smith United States 9 1.1k 0.9× 238 0.4× 330 0.7× 267 1.3× 102 0.9× 15 1.6k
Jeanne-Marie Kíely United States 20 1.2k 1.1× 264 0.5× 600 1.3× 228 1.1× 102 0.9× 26 2.2k
Abraham J. Treves Israel 23 732 0.6× 288 0.5× 327 0.7× 117 0.6× 158 1.4× 78 1.4k
Hung‐Sia Teh Canada 32 2.1k 1.9× 485 0.9× 502 1.1× 199 1.0× 134 1.2× 72 2.8k
D E Kern United States 15 1.5k 1.3× 556 1.0× 351 0.8× 342 1.7× 135 1.2× 21 1.9k
Helen Quill United States 19 1.0k 0.9× 239 0.4× 344 0.8× 217 1.0× 100 0.9× 33 1.5k
Sandra E. Pike United States 19 809 0.7× 767 1.4× 570 1.3× 118 0.6× 100 0.9× 28 1.9k

Countries citing papers authored by Shigeyoshi Fujimoto

Since Specialization
Citations

This map shows the geographic impact of Shigeyoshi Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeyoshi Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeyoshi Fujimoto more than expected).

Fields of papers citing papers by Shigeyoshi Fujimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeyoshi Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeyoshi Fujimoto. The network helps show where Shigeyoshi Fujimoto may publish in the future.

Co-authorship network of co-authors of Shigeyoshi Fujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeyoshi Fujimoto. A scholar is included among the top collaborators of Shigeyoshi Fujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeyoshi Fujimoto. Shigeyoshi Fujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagai, Yasuhiro, Mei Ji, Fuxiang Zhu, et al.. (2019). PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185erbB2/neu Tumor Immunotherapy. Frontiers in Immunology. 10. 174–174. 60 indexed citations
2.
Terunuma, Hiroshi, et al.. (2008). Potential Role of NK Cells in the Induction of Immune Responses: Implications for NK Cell–Based Immunotherapy for Cancers and Viral Infections. International Reviews of Immunology. 27(3). 93–110. 71 indexed citations
3.
Jin, Zhe, Yuan Shen, & Shigeyoshi Fujimoto. (2004). Role of α4 integrin and its ligand VCAM‐1 in the specific extravasation of a tumor‐specific TH2 clone into tumor tissue that initiates its rejection. International Journal of Cancer. 111(4). 558–567. 4 indexed citations
4.
Tanaka, Reiji, Minoru Ikeda, Hideo Yukioka, et al.. (2002). Molecular cloning and cytochemical analysis of exo polygalacturonase from carrot. Planta. 215(5). 735–744. 11 indexed citations
5.
Watanabe, Yoshiya, Sayo Kataoka, Norihito Morimoto, et al.. (2001). Differentiation Stages of Eosinophils Characterized by Hyaluronic Acid Binding via CD44 and Responsiveness to Stimuli. DNA and Cell Biology. 20(4). 189–202. 15 indexed citations
6.
Maeda, Hironori, Shigeyoshi Fujimoto, & Mark I. Greene. (2000). Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vβ8.1 transgenic mice. Proceedings of the National Academy of Sciences. 97(24). 13257–13262. 19 indexed citations
7.
Yan, Jiao & Shigeyoshi Fujimoto. (1998). Sequential T Cell Response Involved in Tumor Rejection of Sarcoma, Meth A, in Syngeneic Mice. Japanese Journal of Cancer Research. 89(6). 657–665. 4 indexed citations
8.
Miyazawa, Hitoshi, Hiroshi Yamamoto, Eiichi Hara, et al.. (1995). INDUCTION OF ANTI-TUMOR IMMUNITY BY MOUSE TUMOR CELLS TRANSFECTED WITH MOUSE INTERLEUKIN-12 GENE. Japanese Journal of Medical Science and Biology. 48(5-6). 221–236. 16 indexed citations
9.
Fujimoto, Shigeyoshi, et al.. (1993). Specific immunosuppression of human anti-murine antibody responses in hu-PBL-SCID mice. Human Antibodies. 4(3). 134–143. 4 indexed citations
10.
Fujimoto, Shigeyoshi, et al.. (1993). T Cell Response to Embryonal Carcinoma F9 Cells: Induction and Characterization of T Cell Receptor αβ+ Double‐negative Cytotoxic T Lymphocytes. Japanese Journal of Cancer Research. 84(1). 58–64. 1 indexed citations
11.
Tamiya, T, et al.. (1992). Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation. Journal of Thoracic and Cardiovascular Surgery. 103(1). 78–86. 3 indexed citations
12.
Tomoda, Takashi, Takanobu Kurashige, Hiroshi Yamamoto, Shigeyoshi Fujimoto, & Taketoshi Taniguchi. (1991). Fluctuation of gene expression for poly(ADP-ribose) syntetase during hemin-induced erythroid differentiation of human leukemia K562 cells and its reversion process. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1088(3). 359–364. 6 indexed citations
13.
Taniguchi, Taketoshi, et al.. (1991). Requirement of down‐regulation of NAD+ ADP‐ribosyltransferase for the interferon‐γ‐induced activation process of murine macrophage tumor cells. European Journal of Biochemistry. 195(2). 557–562. 6 indexed citations
14.
Tomoda, Takashi, Takanobu Kurashige, Toshiaki Moriki, et al.. (1991). Enhanced expression of poly(ADP‐ribose) synthetase gene in malignant lymphoma. American Journal of Hematology. 37(4). 223–227. 64 indexed citations
15.
Numata, Yukiko, Yasushi Matsuura, Saburo Onishi, et al.. (1991). Case report: Interleukin‐6 positive follicular hyperplasia in the lymph node of a patient with rheumatoid arthritis. American Journal of Hematology. 36(4). 282–284. 8 indexed citations
16.
Fujimoto, Shigeyoshi, et al.. (1989). Augmentation of Anti‐tumor Immunity in Low‐responder Mice by Various Biological Response Modifiers: Analysis of Effector Mechanism. Japanese Journal of Cancer Research. 80(12). 1212–1219. 6 indexed citations
17.
Maeda, Nagamasa, et al.. (1989). Augmentation of Human Cytotoxic T Lymphocytes against Autologous Tumor by a Factor Released from Human Monocytic Leukemia Cell Line. Japanese Journal of Cancer Research. 80(6). 537–545. 8 indexed citations
18.
Taniguchi, Taketoshi, Keiko Morisawa, Masaharu Ogawa, Hiroshi Yamamoto, & Shigeyoshi Fujimoto. (1988). Decrease in the level of poly(ADP-ribose) synthetase during nerve growth factor-promoted neurite outgrowth in rat pheochromocytoma PC12 cells. Biochemical and Biophysical Research Communications. 154(3). 1034–1040. 16 indexed citations
19.
Fujimoto, Shigeyoshi, Mark I. Greene, & A.H. Sehon. (1976). Regulation of the Immune Response to Tumor Antigens. The Journal of Immunology. 116(3). 800–806. 102 indexed citations
20.
Fujimoto, Shigeyoshi, Mark I. Greene, & A.H. Sehon. (1976). Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.. PubMed. 116(3). 800–6. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. C. Bansal Breakdown of academic impact, for papers by A Mazumder Breakdown of academic impact, for papers by F W Ruscetti Breakdown of academic impact, for papers by KA Smith Breakdown of academic impact, for papers by Jeanne-Marie Kíely Breakdown of academic impact, for papers by Abraham J. Treves Breakdown of academic impact, for papers by Hung‐Sia Teh Breakdown of academic impact, for papers by D E Kern Breakdown of academic impact, for papers by Helen Quill Breakdown of academic impact, for papers by Sandra E. Pike
Rankless by CCL
2026